4 European Projects Found
Searched on 125080 European Projects
FINISHED
SPIDIA for Personalized Medicine - Standardisation of generic Pre-analytical procedures for In-vitro DIAgnostics for Personalized Medicine (SPIDIA4P)
Start date: Jan 1, 2017, End date: Dec 31, 2020,
Molecular in vitro diagnostics and biomedical research have allowed great progress in personalised medicine but further progress is limited by insufficient guidelines for pre-analytical workflow steps (sample collection, preservation, storage, transport, processing etc.) as well as by insufficient quality assurance of diagnostic practice. This allows using compromised patients’ samples with post c ...
Read Project
21
Partners Participants
FINISHED
Microbial Community-based sequencing analysis linked to anthropogenic pressures: MicroCoKit to address the water quality (MICROCOKIT)
Start date: Jun 1, 2013, End date: May 31, 2017,
Microbial communities are microorganisms (viruses, bacteria, fungi, algae) at the base of the food web pyramid, representing about 50 % of the total biomass on Earth. They are responsible for thebiogeochemical cycles that shape the environment of earth and of its aquatic systems, influencing the health of each trophic and ultimately human health, too.In Europe, the good quality of surface waters i ...
Read Project
5
Partners Participants
FINISHED
Beneficial effects of dietary bioactive peptides and polyphenols on cardiovascular health in humans (BACCHUS)
Start date: Oct 1, 2012, End date: Sep 30, 2016,
"The main objective of the BACCHUS project is to develop tools and resources that will facilitate the generation of robust and exploitable scientific evidence that can be used to support claims of a cause and effect relationship between consumption of bioactive peptides and polyphenols, and beneficial physiological effects related to cardiovascular health in humans. To achieve this, the BACCHUS c ...
Read Project
28
Partners Participants
FINISHED
A pharmacogenomic approach to coumarin anticoagulant therapy (EU-PACT)
Start date: Oct 1, 2008, End date: Mar 31, 2013,
"The effectiveness of treatment with oral anticoagulants in the prevention of thrombotic disorders is well established, but these drugs are potentially dangerous because of their narrow therapeutic index. In Europe three coumarins are used: warfarin, acenocoumarol, and phenprocoumon. Genetic factors that have been recently demonstrated to change the pharmacokinetics and pharmacodynamics of coumari ...
Read Project
